Name: Toremifene Citrate Tablets (Tianheng/Shurui) – 60?mg - Arizona-mall
Price: 1.00 HKD
Availability: InStock

Toremifene Citrate Tablets (Tianheng/Shurui) – 60?mg

$1.00

Toremifene citrate (Tianheng/Shurui) is a selective estrogen receptor modulator (SERM) used in experimental research on hormone receptor pathways. Approved in China (NMPA H20061284; Code?86904561000595) and manufactured by Ningbo Tianheng Pharmaceutical Co., Ltd. Supplied as 60?mg tablets (30 tablets per box, barcode 6944580400383). Strictly for laboratory research only

Compare

描述

Contents hide

1 Toremifene Citrate Product Specifications

2 Toremifene Citrate Mechanism of Action

3 Research & Pharmacology Context

4 Research Applications

Toremifene Citrate Product Specifications

Attribute	Details
Product Name	Toremifene Citrate Tablets (Tianheng/Shurui)
Strength	60?mg per tablet
Quantity	30 tablets per box
Dosage Form	Oral tablet
Approval Number	China NMPA H20061284
Product Code	86904561000595
Barcode	6944580400383
Manufacturer	Ningbo Tianheng Pharmaceutical Co., Ltd.
CAS Number	89778?26?7 (citrate: 89778?27?8) goodrx.com+14en.wikipedia.org+14tajlifesciences.com+14
Molecular Formula	C??H??ClNO? (toremifene citrate)
Molecular Weight	~602?g/mol (citrate salt)
Intended Use	Laboratory research only — Not for clinical or veterinary use

Toremifene Citrate Mechanism of Action

Toremifene is a SERM that binds estrogen receptors, acting as an antagonist in breast tissue and agonist in bones and liver. It inhibits estrogen-driven cancer cell growth and modulates bone/lipid metabolism drugs.com+1cancer.gov+1.

Research & Pharmacology Context

FDA-approved for metastatic estrogen-receptor–positive breast cancer
Features:
- Oral bioavailability ~100%
- Elimination half-life: 3–7 days; active metabolites persist 4–21 days
- Metabolized by CYP3A4 with QT interval prolongation and drug interaction risk

Research Applications

Estrogen receptor signaling and cancer cell growth studies
Bone metabolism and density research
Drug-drug interaction testing (CYP3A4 substrates/inhibitors)
QT interval or cardiac safety assays
Lipid metabolism model investigations

?? Research?Use Only Disclaimer

This product is provided strictly for laboratory research and development use only. Not intended for clinical, veterinary, diagnostic, or therapeutic applications.

其他信息

重量	1.1 公斤
尺寸	18 × 16 × 18 厘米

评价

目前还没有评价

成为第一个“Toremifene Citrate Tablets (Tianheng/Shurui) – 60?mg” 的评价者

Can I use this product for patients?

No. It is strictly for laboratory research, not for clinical, diagnostic, therapeutic, or veterinary applications.

How does Toremifene work?

It binds estrogen receptors; it antagonizes breast tissue (blocking estrogen) and agonizes bone/liver, altering gene expression and growth signaling

What are its common research usages?

It’s used in ER+ breast cancer models, bone density and metabolism assays, drug interaction studies, cardiac safety (QT prolongation), and lipid profile research.

What precautions should I take during experiments?

Handle with proper lab PPE in compliance with cytotoxic and hormonal agent protocols. Monitor storage (<25°C), and avoid contamination with CYP3A4 inhibitors. Dispose of waste properly per institutional regulations.

Are COA/SDS documents available?

Yes — COA and SDS are available upon request for qualified research institutions.